Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Postma

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Global Public Health|July 24, 2023
Economic and humanistic burden of HPV-related disease in Indonesia: A qualitative analysisMarisa Felsher, Didik Setiawan, Stefan Varga, et al.
Journal of Market Access & Health Policy|May 27, 2026
EU-HTA-Why Do Words Matter?Mondher Toumi, Bruno Falissard, Steven Simoens, et al.
Vaccines|June 28, 2023
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert OpinionMaarten Postma, David Fisman, Norberto Giglio, et al.
Vaccine|June 25, 2020
Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable methodRobertus van Aalst, Ellyn M Russo, Nabin Neupane, et al.
Frontiers in Health Services|June 29, 2026
Facilitators and barriers to blood and blood product accessibility and use in sub-Saharan Africa: a systematic reviewAdaeze Oreh, Kobi Vanessa Ajayi, Henshaw Uchechi Okoroiwu, et al.
BMJ Open|December 1, 2022
Impact of digital interdisciplinary consultation on secondary care referrals by general practitioners: a protocol for a stepped-wedge cluster randomised controlled trialSanne Sanavro, Henk van der Worp, Danielle Jansen, et al.
Human Vaccines & Immunotherapeutics|June 5, 2024
The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analysesDavid Fisman, Norberto Giglio, Myron J Levin, et al.
BMJ Open|February 22, 2022
Evaluations of training and education interventions for improved infectious disease management in low-income and middle-income countries: a systematic literature reviewPim Wilhelmus Maria van Dorst, Simon van der Pol, Olawale Salami, et al.
Infectious Diseases and Therapy|November 10, 2018
Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada"Michele R Wilson, Matt Wasserman, Taj Jadavji, et al.
Journal of Market Access & Health Policy|November 19, 2016
Determining the value of medical technologies to treat ultra-rare disorders: a consensus statementMichael Schlander, Silvio Garattini, Peter Kolominsky-Rabas, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Global Public Health|July 24, 2023
Economic and humanistic burden of HPV-related disease in Indonesia: A qualitative analysisMarisa Felsher, Didik Setiawan, Stefan Varga, et al.
Journal of Market Access & Health Policy|May 27, 2026
EU-HTA-Why Do Words Matter?Mondher Toumi, Bruno Falissard, Steven Simoens, et al.
Vaccines|June 28, 2023
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert OpinionMaarten Postma, David Fisman, Norberto Giglio, et al.
Vaccine|June 25, 2020
Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable methodRobertus van Aalst, Ellyn M Russo, Nabin Neupane, et al.
Frontiers in Health Services|June 29, 2026
Facilitators and barriers to blood and blood product accessibility and use in sub-Saharan Africa: a systematic reviewAdaeze Oreh, Kobi Vanessa Ajayi, Henshaw Uchechi Okoroiwu, et al.
BMJ Open|December 1, 2022
Impact of digital interdisciplinary consultation on secondary care referrals by general practitioners: a protocol for a stepped-wedge cluster randomised controlled trialSanne Sanavro, Henk van der Worp, Danielle Jansen, et al.
Human Vaccines & Immunotherapeutics|June 5, 2024
The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analysesDavid Fisman, Norberto Giglio, Myron J Levin, et al.
BMJ Open|February 22, 2022
Evaluations of training and education interventions for improved infectious disease management in low-income and middle-income countries: a systematic literature reviewPim Wilhelmus Maria van Dorst, Simon van der Pol, Olawale Salami, et al.
Infectious Diseases and Therapy|November 10, 2018
Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada"Michele R Wilson, Matt Wasserman, Taj Jadavji, et al.
Journal of Market Access & Health Policy|November 19, 2016
Determining the value of medical technologies to treat ultra-rare disorders: a consensus statementMichael Schlander, Silvio Garattini, Peter Kolominsky-Rabas, et al.
Pageof 10